As manager of Pew's drug safety project, Cosel works on federal initiatives to ensure the safety and oversight of the U.S. pharmaceutical supply chain. Prior to joining Pew, Cosel worked on issues of pharmaceutical safety and appropriate prescribing for national advocacy Organization Community Catalyst, and in grassroots development and capacity-building with the Fund for Public Interest Research in Cambridge, Massachusetts.
Cosel received her M.Sc. in human rights from the London School of Economics and a BA from Yale University.
Recent WorkView All
Pew’s drug safety project has identified over 25 reported compounding errors or potential errors associated with 1,074 adverse events, including 90 deaths, since 2001. Because many such events may go unreported this list is probably an underestimation. Contamination of sterile products was the most common error, though others were the result of pharmacists’ and technicians’... Read More
When compounded drugs are created in large volumes and shipped across the country, as was the case with injections linked to the national meningitis outbreak, producers should meet some of the same quality assurance requirements as drug manufacturers. Read More
Pew and other health care organizations released a report exploring measures that should be considered to address the ongoing issue of drug shortages in the United States, which impacts lifesaving medicines including antibiotics, chemotherapy, and cardiovascular drugs. Read More